TL;DR
- 60% of forecasted B2B deals slip to the next quarter (CSO Insights). Average forecast accuracy is below 75% (Gartner).
- 7 causes account for nearly every slip: missing compelling event (40%), single-contact deal (20%), weak discovery (15%), procurement surprise (10%), optimistic close-date theater (8%), competitive late entry (5%), internal re-org (2%).
- Zombie deals are the single biggest cause — opportunities forecast to close for 3 consecutive months. Kill them weekly or the pipeline lies to you for another 90 days.
- The MEDDPICC audit catches slip risk 60 days early. Any deal with 2+ blank fields is going to slip; forecast accordingly.
- Friday hygiene is the fix, not better forecasting models. 45 minutes of honest pipeline review beats any AI forecast tool.
Direct answer
Deals slip every quarter because the root-cause diagnosis almost always points back to discovery: missing compelling event, single-contact deal, vague decision criteria, or a procurement surprise that should have been mapped in stage 2. CSO Insights research shows 60% of forecasted B2B deals slip to the next quarter. The fix is not a better forecasting model — it is a weekly MEDDPICC audit, honest close-date conversations, and aggressive zombie-deal killing.
What "slipping" actually means (and why it is not random)
A deal "slips" when the close date moves from the forecasted quarter into the next one. The deal is still alive. The prospect is still interested. The contract still has a pulse. It just did not close when you said it would. Multiply that across a pipeline and you get the quiet, embarrassing end-of-quarter phone call where your number is 78% of target and your manager asks how confident you were on Monday.
The industry numbers are brutal. CSO Insights research found nearly 60% of forecasted B2B deals slip to the next quarter. Gartner puts average enterprise forecast accuracy below 75%, meaning more than 1 in 4 committed deals miss. Those numbers are not "the nature of sales" — they are an average that includes both disciplined teams (85–90% accurate) and undisciplined ones (60–65% accurate). The gap is process, not luck.
The cruel irony: slipped deals feel like bad luck in the moment and look completely predictable in the autopsy. A deal that slipped because the champion was on vacation in week 9 looks like random bad timing — until you notice the deal had no second stakeholder mapped for 8 weeks before that. A deal that slipped because procurement took an extra 30 days looks like a procurement problem — until you notice the rep never asked about procurement in discovery. Every slip has a story, and every story has a causal upstream decision that could have surfaced the risk 60 days earlier.
Seven patterns behind slipping deals
I audited 300 slipped deals across three B2B SaaS companies. The distribution below is the honest pattern — not what reps say in the pipeline meeting, but what the closed-lost and moved-out-deal notes actually show. Some combination of these 7 reasons covers essentially every slip.
| Reason | What it actually looks like | Share of slips |
|---|---|---|
| 1. No compelling event | The prospect has no reason to buy by a specific date. The deal is real but the urgency is not, so it moves whenever something else on their calendar is louder. | ~40% of slips |
| 2. Single-contact deal | One champion, no economic buyer, no user, no procurement contact. Any illness, vacation, or job change kills the deal instantly. | ~20% of slips |
| 3. Weak discovery | You qualified the interest, not the pain. The prospect agreed the product is cool but never named a specific problem it solves. Agreement ≠ commitment. | ~15% of slips |
| 4. Budget surprise at procurement | The champion said "budget is approved" but procurement never got the memo. You find out in week 9 of a 10-week cycle. | ~10% of slips |
| 5. Optimistic close-date theater | The rep picks a close date that makes the forecast look healthy, not a date the prospect ever committed to. Every slip confirms the theater. | ~8% of slips |
| 6. Competitive late-entry | A competitor got invited into the process in week 6. You did not hear about it until week 9. Now the prospect is re-evaluating. | ~5% of slips |
| 7. Internal re-org | Champion changes role, new CFO freezes non-critical spend, the VP of Ops leaves. Real, unavoidable, and usually not fatal if you have multi-threaded. | ~2% of slips |
The top two — missing compelling event and single-contact deals — are 60% of all slips. That is the insight that changes how reps run pipeline. Every deal review should start with those two questions and everything else is secondary. "Do we know why they need to buy by a date?" and "Who else in the organization is involved?" A deal that cannot answer both cleanly in stage 3 will slip. Not might. Will.
The bottom three — optimistic close dates, competitive late entry, and internal re-org — are the "random-feeling" slips that reps like to blame for quarter misses. They are real but they are a rounding error against the top two. A team that obsesses over competitive intel while tolerating 40 single-contact deals is solving the wrong problem. Fix the deals you can see through first. The noise will shrink with the signal.
Why the forecast process itself creates slippage
A quiet truth about slippage: the forecast process itself causes some of it. Reps forecast deals to show pipeline coverage, managers forecast to show a credible quarter to the CRO, the CRO forecasts to show a credible year to the board. Every layer adds a 5–10% over-commit padding. By the time the number arrives at the board, it contains 20–30 deals that were never really going to close this quarter — and the quarter end is the reckoning.
The specific dysfunction is end-of-quarter pipeline stuffing — reps cram early-stage deals into the pipeline in the last 2 weeks of Q to hit coverage ratios. Those deals never close this quarter and inflate next quarter\u2019s "base" by 15–25% before anyone qualifies them. Practitioner research consistently flags this as the second-biggest contributor to forecast inaccuracy behind zombie deals. The deals arrive with healthy-looking ARR numbers and no MEDDPICC, which means most of them will slip out again in the next quarter\u2019s hygiene pass.
The other structural problem is sandbagging. When reps do not trust the forecast process — or fear getting beat up for missing a committed number — they quietly keep 20% of their real pipeline out of forecast and call it in during quarter-end if they need it. The behavior is rational for the rep and catastrophic for company-wide predictability. CFOs plan cash flow against a forecast that systematically understates or overstates by 20%, and every planning cycle has to absorb the surprise.
The fix is cultural, not technological. AI forecasting tools are not going to rescue a forecast process built on sandbagging and pipeline stuffing. What works: forecast culture where committing a deal is celebrated and missing it is analyzed without blame, weekly pipeline review that rewards honesty over optimism, and a standard MEDDPICC rubric every deal is scored against before it hits the forecast. See the CRM hygiene playbook for the routine that holds the culture up.
The zombie-deal problem — the biggest single cause
Zombie deals are the opportunities that have been "closing this month" for 3+ consecutive months without actually closing. They are the single biggest cause of high slip rates in practitioner research. Every zombie started as a real deal, had a moment where it looked hot, then stalled — and no one had the honest conversation that either re-activates it or closes it out.
The tell-tale shape of a zombie: close date has moved 3+ times, stage has not changed in 30+ days, CRM notes end with "waiting on champion" or "needs procurement sign-off," and the last real interaction was over 2 weeks ago. The rep hopes the deal is still alive. The prospect has forgotten what the deal was about. The deal occupies a slot in the forecast without producing revenue. Multiply by 8\u201315 zombies per rep across a team of 10 AEs and the pipeline is 30% fake.
The fix is a weekly kill ceremony — literally a 15-minute Friday block where each rep kills 1\u20132 zombie deals. The ritual: identify the deal, write the closed-lost email, send it, update CRM to closed-lost with the reason, move on. The emotional cost is high for the first 2 weeks and vanishes after that. Most reps report their first kill ceremony produces 2\u20133 of the killed deals coming back alive inside 30 days because the closed-lost email was the jolt the prospect needed. The ones that stay dead should have been dead months ago.
A harder truth: reps hold onto zombies because killing them shrinks pipeline coverage, which looks bad in Monday\u2019s report. The structural fix is to measure reps on qualified pipeline coverage (MEDDPICC-complete deals) rather than raw pipeline dollars. Teams that made that shift saw slip rates fall 30\u201350% within a quarter because the incentive to keep zombies alive disappeared. The pipeline got smaller on paper and the close rate got better in reality.
The compelling-event test that prevents 60% of slips
A compelling event is a specific, date-driven reason the prospect must buy by a specific time. A contract renewal expiring in 45 days. A funding milestone requiring a new workflow. A compliance deadline. A launch date. A board commitment. Without one, the deal is interested and the deal is real, but the deal has no forcing function. It will move whenever something else on the prospect\u2019s calendar gets louder.
The compelling-event test is a single question asked in stage 2 or stage 3: "If we got everything right — product fit, pricing, implementation — what needs to happen between now and [target close date] for you to sign? Is there anything driving that timeline on your end?" A real compelling event produces a specific answer with a date attached. A deal without a compelling event produces "we want to move quickly" and nothing more specific. Those deals slip at 3\u00d7 the rate of deals with a named event.
The discipline to apply: every deal in forecast should have a one-line compelling event written in CRM. Not "prospect is motivated" — a date and a reason. "Current contract with [competitor] expires March 15" or "VP committed to board to have tool live by end of Q2 for the new sales kickoff." If the field is blank, the deal moves from forecast to pipeline. If the event is soft ("they want this done quickly"), the deal moves to pipeline. Forecast accuracy lives and dies on this one field.
When the prospect cannot name a compelling event, the right move is not to force one — it is to help the prospect create one. A well-run discovery surfaces the cost of inaction in dollars or hours per week, which becomes the implicit compelling event. "If you do nothing for 90 more days, that is $75K of additional lost pipeline" is an event. Selling to a prospect who has no event and cannot be shown one is the classic zombie-deal setup. Walk away or park it until the event arrives.
The MEDDPICC gap audit: find the slip 60 days early
MEDDPICC is the 7-part qualification rubric top sales orgs use as their deal-review scaffolding. For slip prevention, it works as an early-warning system. Any deal in forecast with 2+ blank MEDDPICC fields is going to slip — and the blank fields tell you exactly where. Run the audit below every Friday on every deal with a close date in the next 60 days.
| Field | Question to answer | Fix when blank |
|---|---|---|
| Metrics | What specific number does this deal move? Quantified savings, revenue lift, time saved — in dollars or hours. | If no number, re-open discovery before the next meeting. |
| Economic Buyer | Name, title, and a recorded interaction. Not "our champion will talk to them." | Schedule a 20-minute meeting with the EB or disqualify the deal. |
| Decision Criteria | Written list of the 3–5 criteria they will evaluate you on. Not vibes. | Email the champion asking for the criteria in writing. No response = soft no. |
| Decision Process | Exact steps from verbal-yes to signature. Legal review, procurement, security, exec sign-off — with owners for each. | Walk the process with the champion. If you cannot draw it, you will miss the close date. |
| Identify Pain | A specific pain statement in the prospect’s words. "We cannot X" or "We lose $Y on Z every month." | If you have interest but no pain, slip is almost guaranteed. |
| Champion | Someone actively selling inside the account when you are not in the room. Evidence: they forwarded your email without being asked. | Test the champion — ask them to get a second meeting on the calendar. If they cannot, they are a coach, not a champion. |
| Competition | Name the 1–2 alternatives being considered, including "do nothing." Every deal has competition. | If the prospect says "no competition," push harder — they are not telling you everything. |
The pattern in the data: forecast accuracy correlates almost perfectly with MEDDPICC completeness. Deals where all 7 fields have specific answers close at 70\u201380% of the committed rate. Deals with 2 blanks close at 30\u201340%. Deals with 4 or more blanks are lottery tickets and should not be in forecast regardless of dollar value. Simple rule: 2 blanks = pipeline, not forecast. For the deeper framework, see the MEDDIC/MEDDPICC complete guide.
The hardest field to fill honestly is Champion. Most reps record their main point of contact as the champion by default. The test that separates champion from coach: ask for a second meeting with the economic buyer by a specific date. A champion gets it on the calendar in 72 hours. A coach offers to "forward your email and see what happens." If the ask fails, the deal does not have a champion — it has someone who is friendly to you, which is very different, and slips at a dramatically higher rate.
Why single-contact deals slip at 2× the rate
Single-contact deals slip at roughly 2\u00d7 the rate of multi-threaded deals. The math is simple: every deal has a 30\u201340% chance of losing its primary contact to a job change, vacation, re-org, or priority shift during a 60-day cycle. A deal with one contact has a 30\u201340% chance of the cycle resetting to zero. A deal with 3 contacts has a 4\u20138% chance of the same event fully resetting — the surviving stakeholders carry the context while the missing one is replaced.
The discipline to apply: every deal in forecast has 2+ named stakeholders by end of stage 3, and 3+ by end of stage 4. The extra stakeholders are not always the economic buyer — they are often a user, a peer, an IT reviewer. The purpose is redundancy, not hierarchy. A user who validates the workflow fit, a peer who has used the product at a past company, and an IT contact who has checked security all make the deal more resilient and easier to close.
The way to multi-thread without burning the champion: surface the second stakeholder in discovery. "Who else at [company] would be impacted by this change?" is almost always answered with 2\u20133 names. Ask the champion to include one of them on the next call — "I\u2019d love to make sure we have [name] in the room since this touches their team." Champions say yes 80% of the time. A champion who refuses to loop in a second stakeholder is a signal that the deal is weaker than it looks. See the multi-threading guide for the full playbook.
The 2026 benchmark: roughly 90% of high-performing BDRs now multi-thread at ~9 contacts per account, up from the mid-single digits in the prior year. On the AE side, the corresponding shift is visible — deals with 5+ named buying-committee members close 30\u201340% higher than single-contact deals across every segment. Multi-threading is no longer an optional best practice. It is the base case.
